DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Call for Papers
    • Exhibition & Sponsorship Opportunities
    • Attending Exhibitors and Sponsors
    • Hotel and Travel
    • New Researcher Network Summer Event
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • ISAM Congress 2026
    • RDD 2026
  • The Aerosol Society logo
Marcus Skogevall

Marcus Skogevall

AstraZeneca

Marcus Skogevall is a Senior Scientist within Global Product Development, Pharmaceutical & Technical Development, AstraZeneca, Gothenburg, Sweden. He has been active in Inhalation research since 2013, focusing on the development and analysis of inhalation devices and formulations, as well as the use of automation in product development. He has been part of the team developing innovative Acoustic Emission and Vibrometry based technologies combined with Machine Learning within the formulation and device development programs at AstraZeneca.
Since joining AstraZeneca in 2004, Marcus has held several positions within AstraZeneca. Before starting his current analytical Science role within Pharmaceutical Product Development in Gothenburg, he worked at Sweden Operations in Södertälje, where he gained experience in a variety of roles, including Quality Assurance and Process Engineer for tablet manufacturing.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk